home / stock / trib / trib news


TRIB News and Press, Trinity Biotech plc From 09/09/21

Stock Information

Company Name: Trinity Biotech plc
Stock Symbol: TRIB
Market: NASDAQ
Website: trinitybiotech.com

Menu

TRIB TRIB Quote TRIB Short TRIB News TRIB Articles TRIB Message Board
Get TRIB Alerts

News, Short Squeeze, Breakout and More Instantly...

TRIB - ProQR Therapeutics, Centessa Pharmaceuticals leads healthcare gainers; Humanigen, Invacare among major losers

Gainers: ProQR Therapeutics (NASDAQ:PRQR) +22%, Centessa Pharmaceuticals CNTA +22%, Kiromic BioPharma (NASDAQ:KRBP) +19%, Trinity Biotech TRIB +16%, Enveric Biosciences (NASDAQ:ENVB) +14%. Losers: Humanigen HGEN -54%, Invacare IVC -34%,&#...

TRIB - Trinity Biotech Announces Results for Q2, 2021

DUBLIN, Ireland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2021. Quarter 2 Results ...

TRIB - Notable earnings before Thursday's open

ASO, OTCPK:DLMAF, HOV, LOVE, TRIB For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Thursday's open

TRIB - Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 Financial Results

DUBLIN, Ireland, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2021 on Thursday, Septem...

TRIB - China SXT Pharmaceuticals, Trinity Biotech leads healthcare gainers; FibroGen, Neptune Wellness Solutions among major losers

Gainers: China SXT Pharmaceuticals (SXTC) +37%, Trinity Biotech (TRIB) +11%, Moderna (MRNA) +9%, Aptevo Therapeutics (APVO) +9%, Apollo Medical (AMEH) +4%.Losers: FibroGen (FGEN) -45%, Neptune Wellness Solutions (NEPT) -20%, Atossa Therapeutic...

TRIB - Trinity Biotech provides business development update for Q2, shares up 8%

Trinity Biotech (TRIB) pops 8% premarket after providing a business development update for Q2 2021. In June 2021, the Company received an update from the WHO on the approval process of TrinScreen HIV. The WHO confirmed that their screening of the submission dossier is comp...

TRIB - Trinity Biotech Provides A Business Development Update For Q2 2021

DUBLIN, Ireland, July 16, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) provides a business development update for Q2 2021. HIV Testing (TrinScreen™ HIV) Trinity Biotech has been the main confirmatory test provider for the detection of the HIV virus on the...

TRIB - Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q1 2021 Results - Earnings Call Transcript

Trinity Biotech plc (TRIB) Q1 2021 Results Conference Call May 25, 2021 11:00 AM ET Company Participants Joe Diaz - Lytham Partners Ronan O’Caoimh - CEO John Gillard - CFO Conference Call Participants Paul Nouri - Noble Equity Funds Jim Sidoti - Sidoti & Co Presentation Operator Go...

TRIB - EDU, PRVB, RIDE and NOVN among midday movers

Gainers: Flanigan's Enterprises (BDL) +73%.Pieris Pharmaceuticals (PIRS) +48%.RYB Education (RYB) +27%.uCloudlink (UCL) +24%.Friedman Industries (FRD) +23%.Taiwan Liposome (TLC) +19%.Provention Bio (PRVB) +19%.The Joint (JYNT) +18%.New Oriental Education & Technology (EDU) +18%....

TRIB - Trinity Biotech slides 7% on Q1 results

Trinity Biotech ([[TRIB]] -6.2%) reports Q1 revenue of $25.6M (+20.9% Y/Y), beating expectations by $1.6M.Clinical laboratory revenues increased to $23.7M, which represents an increase of 32.9% compared to Q1, 2020; the rise in revenue was primarily due to strong sale...

Previous 10 Next 10